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Abstract 
Background: Multi-drug resistant tuberculosis (MDR-TB), defined as resistant to at least isoniazid and rifampicin, has imposed 
serious risks on public health globally. China has the largest number of MDR-TB patients, and a prevalence rate two times of the 
world average. The study investigated the association between MDR-TB treatment outcome and patient risk factors, including 
physical accessibility to TB hospitals. 
 
Methods: We collected all the 336 MDR-TB cases reported in Shanghai between 2009 and 2012 from Shanghai CDC regarding 
information on age, gender, resident status, treatment history, and outcomes. Using the Geographical Information System (GIS), 
TB hospitals and study subjects' locations were geocoded on digital maps. To identify the statistically significant geographical 
clusters, kernel density estimation (KDE) and Average Nearest Neighbor (ANN) index were used. Logistic regression analysis 
was employed to determine the association of spatial and non-spatial variables on the occurrence of poor treatment outcomes.  
 
Results: The spatial clusters of MDR-TB cases were concentrated in the most densely populated central urban areas. There was a 
tendency toward higher odds of poor treatment outcomes among aged>45 years old (aOR 3.251; 95%CI 1.527-7.21), residential 
(aOR 2.566; 95%CI 1.154-5.88), retreated (aOR 2.566; 95%CI 1.154-5.88) and sputum smear positive (aOR 3.286; 95%CI 
1.154-11.66) MDR-TB cases. Both the straight-line distance and the road distance from a patient’s home to the related TB 
hospital were significantly associated with poor treatment outcome with an odds ratio of 1.04 (95%CI 1.009-1.08) and 1.029 
(95%CI 1.005-1.06) respectively.  
 
Conclusion: This study highlights the effect of spatial and non-spatial determinants of MDR-TB treatment outcome, particularly 
with regard to physical accessibility to the TB hospitals. Accordingly, non-spatial factors in terms of previous treated status need 
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for more attention by public health policy makers, and then more focus should be placed on the health delivery system, 
particularly in elderly patients. In addition, using the GIS application with a view to MDR-TB distribution and physical 
accessibility to hospitals is a novel method in Shanghai and it can be developed to reach other related public health disciplines. 
 
© 2016 The Authors. Published by Elsevier B.V. 
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1. Introduction 
Tuberculosis (TB) is re-emerging as one of the top challenges in China. Multi-drug resistant tuberculosis (MDR-
TB), defined as resistant to at least isoniazid and rifampicin, is a major barrier to TB control, especially in high 
burden countries such as China1. The World Health Organization (WHO) estimates that China has the second largest 
number of MDR-TB cases globally2. The national baseline TB survey in 2007–2009 found that 8.3 % of cases were 
MDR-TB, predicting approximately 120,000 new MDR-TB cases annually, and 5.7% of new cases and 25.6% of 
previously treated cases had MDR-TB3.  
The Chinese government started the programmatic management of MDR-TB in 2008, supported by the Global 
Fund to Fight AIDS, TB and Malaria (The Global Fund, Geneva, Switzerland). Laboratory and clinical capacity was 
strengthened in designated TB hospitals at the prefectural level to turn them into MDR-TB diagnosis and treatment 
centers4. MDR-TB requires prolonged treatment with costly second-line anti-TB drugs (SLD), leading to health 
system opportunity costs, adverse effects, and financial impacts for patients5-7. Patients with MDR-TB have a low 
treatment success rate: 48 % globally and 50 % in China8. Recurrence and treatment failure are more common for 
drug resistant than drug sensitive TB9, 10, and the treatment outcomes of MDR TB patients have been less favorable 
than that of TB patients whose disease is caused by a susceptible strain of M. tuberculosis11, 12.  
In spite of the evidence indicating the contribution of non-spatial characteristics, including age, gender, low 
education achievement, domicile and social class to determine the outcomes of MDR-TB treatment13, 14, the spatial 
factor in terms of physical accessibility to the related TB hospitals during the treatment course has been less 
considered. Moreover, reasons for poor treatment outcomes are multifaceted and involve a combination of spatial 
and non-spatial factors, along with how health policy was formulated to deliver health care services15, 16.  
Shanghai, an international metropolis, is the most populous city in China, with more than 23 million inhabitants 
in 201017. The health needs and implications of this sizeable population are considerable and constitute a vast 
challenge to its public health. There are a few studies on spatial patterns of TB and their related treatment outcomes 
that have focused on non-spatial factors. These studies have shown a link between ethnicity, previous unsuccessful 
treatment, age and sex with anti-TB drug resistance18-20; however, information on the effect of spatial and non-spatial 
determinants on MDR-TB treatment outcomes is scare. Therefore, this retrospective study aimed to address whether 
or to what extent spatial and non-spatial factors with a focus on the healthcare delivery system would affect 
successful MDR-TB treatment outcomes in Shanghai.  
2. Methods 
2.1. Study area and population 
Shanghai had a total of 16 sub-districts, and were further divided as central urban, peri-urban and rural areas 
according to the population density and economic functions21. We performed a retrospective cohort study using the 
existing data of all MDR-TB patients who were diagnosed and reported by the Shanghai TB Program at the 
Shanghai CDC from 01 Jan 2009 to 31 Dec 2012. In China, passive case finding was the major method to identify 
adult patients who are susceptive of having TB, i.e., those who have coughed over 2 weeks, having fever, weight 
loss, night sweats and abnormal chest radiography were referred or self-referred to the TB designated hospitals, 
where they were diagnosed of TB according to China national guidelines. All patients provided three sputum 
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license 
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
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samples for acid-fast bacilli, and 2 of them were sent for Lowenstein-Jensen solid culture in the central reference 
laboratory. Based on positive culture results, all cases were given drug susceptibility tests on rifampin and isoniazid, 
where MDR-TB was defined as resistant at least to both rifampin and isoniazid. In addition, we collected 
information in the TB registry regarding their age, sex, residence status, residential address, history of previous anti-
TB treatment, and sputum smear examination results at the time of their diagnosis. 
2.2. TB control network and program 
Shanghai has an integrated TB control network involving Centers for Disease Control and Prevention (CDCs), 
TB hospitals, general hospitals and community health centers (CHCs). CDCs are mainly responsible for 
epidemiological surveillance and for developing and implementing TB control programs and strategies. TB hospitals 
are mainly responsible for TB case diagnosis, treatment, and case notifications. General hospitals perform case 
detection and refer TB suspects to TB hospitals. CHCs are responsible for finding and tracking the suspect TB cases 
that are referred to the TB hospitals by the general hospitals, and for performing case management and health 
education22, 23.  
2.3. Definitions 
New TB cases were defined as TB patients who have never been treated for TB or have taken anti-TB drugs for 
less than 1 month. Previously treated patients were those who have received 1 month or more of anti-TB drugs in 
the past24. Migrants were defined as individuals from other areas of China and residents were defined as persons 
with a registered permanent residence in Shanghai. The treatment outcomes were classified into the following 
groups in accordance with the suggested criteria of WHO: cured, treatment completed, treatment failed, died, lost to 
follow-up and not evaluated. Cured was defined as a patient who had completed treatment according to program 
protocol and had been consistently culture-negative for the final 12 months of treatment for TB. Treatment 
completed was defined as a patient who had completed treatment but does not meet the definition for cured. Died 
was defined as a patient who died for any reason during the course of TB treatment. Treatment was considered to 
have failed if two or more of the five cultures recorded in the final 12 months of therapy were positive, or if any one 
of the final three cultures was positive. Lost to follow up was defined as a patient whose treatment was interrupted 
for 2 consecutive months or more. Not evaluated was defined as a patient for whom no treatment outcome is 
assigned (This includes cases “transferred out” to another treatment unit and whose treatment outcome is unknown). 
Based on these classifications, the treatment outcomes were further categorized into treatment success (for cured and 
treatment completed) or poor treatment outcomes (for died and failed) 24.  
2.4. Spatial analysis 
We geocoded all patients’ residential addresses at the time their MDR-TB diagnosis and all TB hospitals of 
Shanghai using the Google geocoding service. 
The Average Nearest Neighbor (ANN) index was applied based on the straight-line distances from each MDR-
TB case to its nearest neighboring case to identify aggregations. Values of the ANN index that are greater than the 
upper limit of the Z score indicate concentration, while values of the ANN index less than the lower limit of the Z 
score indicate dispersion. The toolbox of the Arc Map software version 10.2 was used for calculation of ANN index. 
KDE was used to map the spatial point pattern for all MDR-TB patients. The quartic kernel function was used, 
with the kernel width parameter selected to minimize the mean square error for each smoothed surface25, 26. 
In order to measure the distance from a patient's home to the related TB hospital, both the straight-line distance, 
and road distance were employed. The road distances were calculated using Google maps.  
2.5. Statistical analyses 
Statistical analysis of the collected data was performed using R software version 3.2.3. (The R Foundation for 
Statistical Computing). Comparisons of demographic, socioeconomic and TB-related characteristics between patient 
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subgroups were performed using the Chi-squared test and Two Sample T-test was used for comparison of mean 
value. A multivariate logistic regression analysis was performed to identify the association between poor treatment 
outcome and the distance from a patient’s home to the TB hospital, adjusting variables including gender, age, TB 
treatment history, diagnostic sputum smear test results, residential status, and domicile. 
2.6. Ethics issues  
Ethics exemption was obtained from the Survey and Behavioral Research Ethics Committee of the Chinese 
University of Hong Kong, Hong Kong, China. 
3. Results 
3.1. General characteristics of the study population  
From 1 January 2009 to 31 December 2012, a total of 367 patients diagnosed with MDR-TB were registered to 




Fig. 1. Flow chart on the number of patients include in the analysis. 
The characteristics of MDR-TB patients and univariate analysis of socio demographic characteristics with respect 
to treatment outcomes are presented in Table 1. Of these 269 patients, 199 (74%) were men. 133 MDR-TB patients 
were migrants, accounting for 49.4% of the total. Previously treated patients accounted for 42.8% (115/269). 84% of 
the patients were sputum smear positive. The proportion of poor treatment outcomes was higher among patients 
aged >45 years (39.2% versus 10.4%; p<0.001). A greater proportion of poor treatment outcomes were found to be 
residents (35.3% versus 12%; p<0.001). Compared with new cases, there was a significantly higher proportion of 
poor treatment outcomes among previously treated cases (32.2% versus 17.5%; p=0.005). The proportion of poor 
treatment outcomes was higher among smear positive patients (26.1% versus 11.6%; p=0.041). The straight-line 
distance and road distance from a patient’s home to the related TB hospital were greater among patients with poor 
treatment outcomes (median 7.6 km versus 6.2 km, p=0.2; and median 8.6 km versus 10.0 km, p=0.2).  
Table 1. Demographic and Clinical Characteristics of MDR-TB patients in Shanghai, 2008-2012 
Treatment outcomes 
Characteristics Total (%) Successful Poor P-value 
No. 269 205 64 
Gender 
Female 70 (26) 59 (84.3) 11 (15.7) 
Male 199 (74) 146 (74.3) 53 (26.7) 0.065 
Age group 
Age45 144 (53.5) 129 (89.6) 15 (10.4) 
336 patients with an CDC record
367 MDR-TB patients with an isolate available
23 patients transferred out and 44 patients with treatment 
outcomes unknown
269 patients available for analysis
31 patients whose CDC record missed
7,982 culture positive PTB patients had DST, 2009-2012
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Age>45 125 (46.5) 76 (60.8) 49 (39.2) <0.001 
Residence 
Migrants 133 (49.4) 117 (88) 16 (12) 
Residents 136 (50.6) 88 (64.7) 48 (35.3) <0.001 
Patient Category 
New 154 (57.2) 127 (82.5) 27(17.5) 
Previous 115 (42.8) 78(67.8) 37 (32.2) 0.005 
Sputum smear result 
Negative 43 (16) 38 (88.4) 5 (11.6) 
Positive 223 (84) 167 (73.9) 59 (26.1) 0.041 
Districts 
Rural areas 67 (24.9) 50 (74.6) 17 (25.4) 
Peri-urban 112 (41.6) 91 (81.2) 21 (18.8) 0.294 
Central urban 90 (33.5) 64 (71.1) 26 (28.9) 0.625 
Median, [IQR] Median, [IQR] Median, [IQR] 
Straight-line distance to hospital 6.5 [2.9,12.2] 6.2 [2.9,11.5] 7.6 [3.0,13.9] 0.2 
Road distance to hospital 8.8 [4.0,16.7] 8.6 [4.1,15.9] 10.0 [4.0,19.3] 0.2 
 
3.2. Geographical distribution of MDR-TB patients 
Using the ANN index, it identified significant nonrandom dispersion of MDR-TB cases into context (ANN 
index: 0.604 Z score = -13.885 and P value = 0.0001) with observed and expected mean distances of 13.66 km and 
22.62 km, respectively. The kernel density map of the residential address of all the patients, was presented in Fig. 2. 
The map suggested that patients were concentrated in the central districts of Shanghai.  
 
Fig. 2. The kernel density map of the residential address of all the MDR-TB patients 
3.3. Factors associated with poor treatment outcome 
Table 2 presents the results of multivariate logistic regression analysis. The following factors were significantly 
associated with poor treatment outcomes: aged >45 years old (aOR 3.251; 95%CI 1.527-7.21), previously treated for 
TB (aOR 2.566; 95%CI 1.154-5.88) and the sputum smear positive result (aOR 3.286; 95%CI 1.154-11.66). The 
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odds ratio (OR) of poor treatment outcomes was 2.566 (95%CI 1.154-5.88) for cases among permanent residents 
versus cases among migrants. No significant differences regarding poor treatment outcomes were observed through 
gender and domicile groups. Both the straight-line distance and the road distance from a patient’s home to the 
related TB hospital were significantly associated with poor treatment outcomes with an odds ratio of 1.04 (95%CI 
1.009-1.08) and 1.029 (95%CI 1.005-1.06), respectively. 
Table 2. Results of multivariate logistic regression analysis of the risk factors associated with poor treatment outcome 
Characteristics Adjusted OR (95% CI)  P-value 
N       
Gender    
  Female 1    
  Male 1.085 (0.483, 2.55)  0.847 
Age group      
  Age<45 1    
  Age>45 3.251 (1.527, 7.21)  0.003 
Residence    
  Migrants 1    
  residents 2.566 (1.154, 5.88)  0.022 
Patient Category      
New 1    
Previous 2.044 (1.094, 3.86)  0.026 
Sputum smear result    
  Negative 1    
  Positive 3.286 (1.154, 11.66)  0.040 
Districts      
  Rural areas 1    
  Peri-urban 0.969 (0.425, 2.26)  0.941 
  Central urban 1.111 (0.46, 2.73)  0.815 
       
Straight-line distance to hospital 1.04 (1.009, 1.08)  0.017 
Road distance to hospital  1.029 (1.005, 1.06)  0.021 
4. Discussion 
4.1. Main findings 
This is the first study with an integrated approach to highlight the effect of spatial and non-spatial determinants 
on MDR-TB treatment outcomes.  
The univariate analysis showed that the non-spatial factors, including aged>45 years old, resident status, previous 
treatment history, and sputum smear positive were associated with poor MDR-TB treatment outcomes. In addition, 
the proportion of poor treatment outcomes did not vary significantly across different areas of Shanghai. Moreover, 
MDR-TB cases are not distributed at random, and there is a strong heterogeneity across the geographic areas of 
Shanghai, of which the most likely cluster was detected in the most densely populated areas, namely central urban 
areas. The multivariate analysis highlighted distance from the patient’s home to the related TB hospital as a 
significant risk factor for poor treatment outcomes.  
The demographic and clinical characteristics of the patients have been shown to play a significant role in the 
occurrence of diseases including their behavior towards the treatment. The importance of age in patient adherence to 
treatment was reported by Wu et al in Taiwan. They reported that elderly patients had poorer treatment outcomes 
because they needed additional support to access TB treatment27. Our study showed a significant association 
between age and poor treatment outcomes as well. We also found that the proportion of poor treatment outcomes 
was higher among previously treated TB cases than among new TB cases as in the previous study conducted in 
Shanghai as well28. Our observation that having positive smears at the time of diagnosis is independently associated 
with poor treatment outcomes in MDR-TB cases is in accordance with the findings from other studies1, 29. This may 
be explained by the fact that smear-positive patients often have more severe disease and a longer delay before the 
initiation of the treatment. Previous studies showed that migrant status was a risk factor associated with poor 
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treatment outcomes in patients with MDR-TB30. Studies confirmed the migrant population contribution to the 
incidence of TB and the differences were reported among the 18 districts in Beijing20, 31. These findings contrast the 
results of our study, which showed residents were more likely to have poor treatment outcomes than migrants with 
an odds ratio of 2.566. One cause of the contradiction could be many migrants transferred out during their treatment 
leading to treatment outcomes not evaluated, which could consequently affect the accuracy of analytical results. 
Access to TB treatment is one of the key determinants for effective TB control services. The lack of access due to 
geographical distance to a healthcare center was found to be related to default or failure treatment outcome in 
developing countries14, 32. Distance may limit patient access to the services, especially for the daily direct 
observation of the treatment (DOT) which takes place in the health facility during the intensive phase of treatment. 
Free TB treatment policy is being implemented in Shanghai with the main aim of reducing cost to the patient. 
However, the patients have to pay their travel cost to the TB hospital to access the service. MDR-TB treatment takes 
a longer duration than TB treatment, which usually takes more than 2 years. Those patients who are already 
impoverished by the disease are also faced with additional costs for transporting themselves to access the TB 
services making them more likely to interrupt treatment. We found that the longer the distance from one patient’s 
home to the TB hospital, the worse the treatment outcome was. Our findings are in accordance with those reported 
by O'Boyle et al in Malaysia33 and Kandel et al in South Africa34. They reported long distance, costs of travel and 
travel time as the major risk factor for interruption of treatment among TB patients. 
4.2. Strength and limitations 
This is the first study in Shanghai to use a holistic approach toward spatial and non-spatial determinants of MDR-
TB treatment outcomes. Both the geographical distance and the road distance were used as a proxy for physical 
accessibility to the TB hospitals. Nevertheless, some limitations should be considered. Previous studies revealed that 
lack of knowledge of the duration of treatment was significantly associated with interruption of treatment. 
Behavioral factors of the patients, especially cigarette smoking and alcohol use have been shown to have negative 
effects on TB treatment. We did not explore these important factors. Furthermore, MDR-TB treatment involves a lot 
of interaction between patients and health care workers. Thus the attitude of the health care workers towards the 
patient remains an important factor that affect the treatment process. However, it was not included within the scope 
of this study. This subject makes for an interesting topic for future investigations. 
5. Conclusion 
This study highlights the effect of spatial and non-spatial determinants of MDR-TB treatment outcomes, 
particularly with regard to physical accessibility to the TB hospitals. Accordingly, non-spatial factors in terms of 
previous treated status need for more attention by public health policy makers, and then more focus should be placed 
on the health delivery system, particularly in elderly patients. In addition, using the GIS application with a view to 
MDR-TB distribution and physical accessibility to hospitals is a novel method in Shanghai and it can be developed 
to reach other related public health disciplines. 
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